Pliant Therapeutics, Inc. (PLRX)
1.01
+0.01
(+1.00%)
USD |
NASDAQ |
Oct 09, 15:32
Pliant Therapeutics Net Income (Quarterly) : -22.37M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -22.37M |
| March 31, 2026 | -20.04M |
| December 31, 2025 | -23.58M |
| September 30, 2025 | -26.30M |
| June 30, 2025 | -43.30M |
| March 31, 2025 | -56.17M |
| December 31, 2024 | -49.73M |
| September 30, 2024 | -57.76M |
| June 30, 2024 | -55.85M |
| March 31, 2024 | -46.96M |
| December 31, 2023 | -41.11M |
| September 30, 2023 | -41.49M |
| June 30, 2023 | -41.19M |
| March 31, 2023 | -37.55M |
| December 31, 2022 | -35.06M |
| Date | Value |
|---|---|
| September 30, 2022 | -30.62M |
| June 30, 2022 | -29.55M |
| March 31, 2022 | -28.10M |
| December 31, 2021 | -24.53M |
| September 30, 2021 | -27.04M |
| June 30, 2021 | -22.83M |
| March 31, 2021 | -22.86M |
| December 31, 2020 | -19.03M |
| September 30, 2020 | -16.53M |
| June 30, 2020 | -17.00M |
| March 31, 2020 | 11.03M |
| December 31, 2019 | 42.17M |
| September 30, 2019 | -13.26M |
| June 30, 2019 | -15.52M |
| March 31, 2019 | -14.02M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | -8.603M |
| CorMedix, Inc. | 25.99M |
| Eloxx Pharmaceuticals, Inc. | -4.502M |
| BioStem Technologies, Inc. | -8.971M |
| Wave Life Sciences, Inc. | -69.36M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 22.37M |
| EPS Diluted (Quarterly) | -0.3613 |
| Enterprise Value | -67.44M |
| Earnings Yield | -148.3% |
| Normalized Earnings Yield | -143.28 |